MUC1-mediated induction of myeloid-derived suppressor cells in patients with acute myeloid leukemiaAthalia R. Pyzer, David Avigan, Dina Stroopinsky et al.|Blood|2017Cited by 193
Individualized vaccination of AML patients in remission is associated with induction of antileukemia immunity and prolonged remissionsJacalyn Rosenblatt, David Avigan, Richard M. Stone et al.|Science Translational Medicine|2016Cited by 165
Mucin 1 is a potential therapeutic target in cutaneous T-cell lymphomaSalvia Jain, David Avigan, Dina Stroopinsky et al.|Blood|2015Cited by 37
Shariant platform: Enabling evidence sharing across Australian clinical genetic-testing laboratories to support variant interpretationEmma Tudini, Michael C. Quinn, Sarah L. King‐Smith et al.|The American Journal of Human Genetics|2022Cited by 34
Blockade of PD-1 in Combination with Dendritic Cell/Myeloma Fusion Cell Vaccination Following Autologous Stem Cell Transplantation Is Well Tolerated, Induces Anti-Tumor Immunity and May Lead to Eradication of Measureable DiseaseJacalyn Rosenblatt, David Avigan, Irit Avivi et al.|Blood|2015Cited by 12